# Metronidazole

## Frotin 250mg suppository

##### 

| TAH Drug Code      | [EFRO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EFRO)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Vaginitis due to trichomonas vaginalis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | 1 suppository at bedtime for 10-21 days, after treatment 1-2 weeks or at menstrual cycle ending < 3 months must have trichomonas test.                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Blood dyscrasias. Active CNS disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | GI upset, urticaria, angioedema. Rarely, drowsiness, skin reactions, darkening of urine, anaphylaxis, neuropathy, encephalopathy. Gastrointestinal: Abdominal discomfort (7%), Loss of appetite, Metallic taste, Nausea and vomiting (4%) Immunologic: Jarisch Herxheimer reaction Neurologic: Dizziness (1% to 4% ), Headache (tablets, 15% to 18%; vaginal gel, 5% ), Peripheral neuropathy Reproductive: Candida infection of genital region, Symptomatic cervicitis/vaginitis (10%), Vaginal discharge (12%) Other: Drug interaction with alcohol, Disulfiram-like reaction |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | Hold Breast Feeding                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

## Sutrol gel-vaginal 7.5mg/gm, 25gm

##### 

| TAH Drug Code      | [ESUT](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ESUT)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of vag infections such as Hemophilus vaginitis, Gardnerealla vaginitis, nonspecific vaginitis, Corynebacterium vaginitis or anaerobic vaginosis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | Apply 5 g QD-BID for 5 days. Apply before bedtime if to be used once daily.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Hypersensitivity to parabens or other nitroimidazole.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Vag discomfort, vag candidiasis, vag irritation, pelvic discomfort. GI disturbances, nausea, vomiting, unpleasant smell, diarrhea, loss of appetite, flatulence, dry mouth. Headache, dizziness, depression. Itch or rash. Skin irritation. Gastrointestinal: Abdominal discomfort (7%), Loss of appetite, Metallic taste, Nausea and vomiting (4%) Immunologic: Jarisch Herxheimer reaction Neurologic: Dizziness (1% to 4% ), Headache (tablets, 15% to 18%; vaginal gel, 5% ), Peripheral neuropathy Reproductive: Candida infection of genital region, Symptomatic cervicitis/vaginitis (10%), Vaginal discharge (12%) Other: Drug interaction with alcohol, Disulfiram-like reaction |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | Hold Breast Feeding                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

